CLINICAL_TRIALS
trial_result
· 2008-03-04
Clinical Trial Update: A Phase I Study of SU101 in Pediatric Patients With Refractory Malignancy [Phase 1]
Summary
A Phase I study evaluating SU101 in pediatric patients with refractory glioma or sarcoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Glioma, Sarcoma | Phase 1 | Status: COMPLETED